Author | Cruz, Aline C. | |
Author | Neves, Bianca C | |
Author | Higa, Laurinda Yoko Shinzato | |
Author | Folescu, Tânia Wrobel | |
Author | Marques, Elizabeth A. | |
Author | Milagres, Lucimar G. | |
Access date | 2013-02-05T14:03:06Z | |
Available date | 2013-02-05T14:03:06Z | |
Document date | 2012 | |
Citation | CRUZ, Aline C. et al. Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients. APMIS acta pathol. microbiol. immunol. scand., Copenhagen, v. 120, n. 8, p. 622-627, aug. 2012 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/6296 | |
Language | eng | pt_BR |
Publisher | Munksgaard | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Do¨ ring G, Conway SP, Heijerman HG, Hodson
ME, Høiby N, Smyth A, et al. Antibiotic therapy
against Pseudomonas aeruginosa in cystic
fibrosis: a European consensus. Eur Respir
J 2000;16:749–67. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Milagres LG, Castro TLA, Garcia D, Cruz AC,
Higa L, Folescu T, et al. Antibody response to
Pseudomonas aeruginosa in children with cystic
fibrosis. Pediatr Pulmonol 2009;44:392–401. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | West SE, Zeng L, Lee BL, Kosorok MR, Laxova
A, Rock MJ, et al. Respiratory infections
with Pseudomonas aeruginosa in children with
cystic fibrosis: early detection by serology and
assessment of risk factors. JAMA 2002;12:2958–
67. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Corech R, Rao A, Laxova A, Moss J, Rock
MJ, Li Z, et al. Early immune response to the
components of the type III system of Pseudomonas
aeruginosa in children with cystic fibrosis.
J Clin Microbiol 2005;43:3956–62. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Jain M, Ramirez D, Seshadri R, Cullina JF,
Powers CA, Schulert GS, et al. Type III secretion
phenotypes of Pseudomonas aeruginosa
strains change during infection of individuals
with cystic fibrosis. J Clin Microbiol 2004;42:
5229–37. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Blonder-Hill E, Henry DA, Speert DP. Pseudomonas.
In: Murray PR, Baron EJ, Jorgensen
JH, Landry ML, Pfaller MA, editors. Manual
of Clinical Microbiology. Washington, DC,
ASM Press, 2007. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Saliba AM, Filloux A, Ball G, Silva ASV, Assis
MC, Plotkowski MC. Type III secretion-mediated
killing of endothelial cells by Pseudomonas
aeruginosa. Microb Pathog 2002;33:153–66. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Wedege E, Bolstad K, Wetzler LM, Guttormsen
HK. IgG antibody level to meningococcal
porins in patient sera: comparison of immunoblotting
and ELISA measurements. J Immunol
Methods 2000;24:9–15. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Li L, Ledizet M, Kar K, Koski RA, Kazmierczak
BI. An indirect enzyme-linked immunosorbent
assay for rapid and quantitative assessment
of Type III virulence phenotypes of Pseudomonas
aeruginosa isolates. Ann Clin Microbiol
Antimicrob 2005;4:22–35. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Sawa T, Yahr TL, Ohara M, Kurahashi K,
Gropper MA, Wiener-Kronish JP, et al. Active
and passive immunization with the Pseudomonas
V antigen protects against type III intoxication
and lung injury. Nat Med 1999;5:392–8. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Goure J, Pastor A, Faudry E, Chabert J, Dessen
A, Attree I. The V Antigen of Pseudomonas
aeruginosa is required for assembly of the
functional PopB/PopD translocation pore in
host cell membranes. Infect Immun 2004;72:
4741–50. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Farrel PM, Govan JRW. Pseudomonas serology:
confusion, controversy, and challenge. Thorax
2006;61:645–7. | pt_BR |
xmlui.metadata.dc.relation.isbasedon | Pressler T, Frederiksen B, Skov M, Garred P,
Koch C, Hoiby N. Early rise of anti-Pseudomonas
antibodies and a mucoid phenotype of Pseudomonas
aeruginosa are risk factors for
development of chronic lung infection-a case
control study. J Cyst Fibros 2006;5:9–15. | pt_BR |
Rights | restricted access | |
Title | Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients | pt_BR |
Type | Article | |
DOI | 10.1111/j.1600-0463.2012.02888.x | |
Abstract | Pseudomonas aeruginosa is associated with increased mortality in cystic fibrosis (CF) patients, and expresses type III secretion system proteins (TTSP), which is a common mechanism used by gram-negative pathogens for delivery of anti-host factors. Our aim was to investigate whether or not these antigens (TTSP) would be recognized by CF sera, by Western blot reaction. We have showed herein that all patients (n = 11) not chronically infected by P. aeruginosa had their first serum positive for TTSP (ExoS, ExoT, PopB, and/or PopD). All chronic patients had a strong positive serology to TTSP, although relatively weak reactions to TTSP were observed for some individuals in the negative control group. Therefore, TTSP that were early produced in P. aeruginosa infected CF patients, induced a detectable antibody response in those patients and were easily detected by Western-blot reaction. | pt_BR |
Affilliation | Universidade do Estado do Rio de Janeiro. Departamento de Microbiologia, Imunologia e Parasitologia. Rio de Janeiro, RJ, Brasil | pt_BR |
Affilliation | Universidade Federal do Rio de Janeiro. Instituto de Química. Deparamento de Bioquímica. Rio de Janeiro, RJ, Brasil | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Departamento de Pulmonologia. Rio de Janeiro, RJ, Brasil | pt_BR |
Affilliation | Fundação Oswaldo Cruz. Instituto Fernandes Figueira. Departamento de Pulmonologia. Rio de Janeiro, RJ, Brasil | pt_BR |
Affilliation | Universidade do Estado do Rio de Janeiro. Departamento de Microbiologia, Imunologia e Parasitologia. Rio de Janeiro, RJ, Brasil | pt_BR |
Affilliation | Universidade do Estado do Rio de Janeiro. Departamento de Microbiologia, Imunologia e Parasitologia. Rio de Janeiro, RJ, Brasil | pt_BR |
Subject | Antibody Response | pt_BR |
Subject | P. Aeruginosa | pt_BR |
Subject | Pulmonary Infection | pt_BR |
Subject | Diagnosis | pt_BR |
Subject | Cystic Fibrosis | pt_BR |
DeCS | Infecções por Pseudomonas | pt_BR |
DeCS | Pseudomonas aeruginosa | pt_BR |
DeCS | Infecções Respiratórias | pt_BR |
DeCS | Fibrose Cística | pt_BR |